FibroBiologics, Inc.
FBLG
$1.06
-$0.09-7.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.12M | -5.00M | -3.24M | -5.78M | -4.66M |
| Total Depreciation and Amortization | 161.00K | 237.00K | 234.00K | 231.00K | 206.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 625.00K |
| Total Other Non-Cash Items | 675.00K | 640.00K | 1.18M | 1.52M | 322.00K |
| Change in Net Operating Assets | -10.00K | -241.00K | -1.34M | 58.00K | -479.00K |
| Cash from Operations | -3.29M | -4.36M | -3.16M | -3.97M | -3.98M |
| Capital Expenditure | -- | -- | 0.00 | -6.00K | -213.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -6.00K | -213.00K |
| Total Debt Issued | 0.00 | 327.00K | 0.00 | 0.00 | 4.38M |
| Total Debt Repaid | -122.00K | -81.00K | -3.40M | -- | -- |
| Issuance of Common Stock | 2.86M | 706.00K | 6.59M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.58M | -- | -- | -- | -- |
| Cash from Financing | 5.32M | 952.00K | 3.19M | 0.00 | 4.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.03M | -3.41M | 27.00K | -3.98M | 178.00K |